-+ 0.00%
-+ 0.00%
-+ 0.00%

Truist Securities Maintains Buy on Disc Medicine, Raises Price Target to $115

Benzinga·10/20/2026 15:38:11
Listen to the news
Truist Securities analyst Danielle Brill maintains Disc Medicine (NASDAQ:IRON) with a Buy and raises the price target from $83 to $115.